Provided by Tiger Trade Technology Pte. Ltd.

Metagenomi Technologies, LLC

1.10
-0.0300-2.65%
Post-market: 1.100.00000.00%19:30 EDT
Volume:124.38K
Turnover:139.02K
Market Cap:41.55M
PE:-0.44
High:1.14
Open:1.12
Low:1.10
Close:1.13
52wk High:3.95
52wk Low:1.10
Shares:37.78M
Float Shares:25.57M
Volume Ratio:1.06
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4900
EPS(LYR):-2.3634
ROE:-60.61%
ROA:-28.19%
PB:0.37
PE(LYR):-0.47

Loading ...

Metagenomi Is Maintained at Overweight by Wells Fargo

Dow Jones
·
May 12

Analysts Are Bullish on Top Healthcare Stocks: Aktis Oncology, Inc. (AKTS), Metagenomi, Inc. (MGX)

TIPRANKS
·
May 12

Metagenomi Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Metagenomi Highlights Q1 Progress on MGX-001 Gene Therapy

TIPRANKS
·
May 12

Metagenomi reports Q1 EPS (61c), consensus (55c)

TIPRANKS
·
May 12

Metagenomi Q1 EPS $(0.61) Misses $(0.55) Estimate, Sales $1.248M Miss $5.925M Estimate

Benzinga Earnings
·
May 12

Metagenomi Q1 FY26 net loss narrows to $23.06 million; revenue drops to $1.25 million

Reuters
·
May 12

Metagenomi Therapeutics Inc - Q1 Net Loss per Share $0.61

THOMSON REUTERS
·
May 12

Press Release: Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

Dow Jones
·
May 12

Metagenomi Therapeutics Inc expected to post a loss of 53 cents a share - Earnings Preview

Reuters
·
May 07

Metagenomi Therapeutics announces annual shareholder meeting

Reuters
·
Apr 28

MGX Resources Reports Lower March Quarter Iron Ore Sales; Shares Rise 3%

MT Newswires Live
·
Apr 24

Macmahon Named Preferred Contractor for $38m Groundrush Decline

TIPRANKS
·
Apr 21

Macmahon Named Preferred Contractor for $38m Groundrush Underground Project

TIPRANKS
·
Apr 21

Metagenomi reports compact CRISPR nuclease MG119-28 shows higher genome-editing efficiency

Reuters
·
Apr 16

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

GlobeNewswire
·
Apr 16

MGX Resources to Relocate Registered Office in West Perth

TIPRANKS
·
Apr 15

OpenAI Nearing $10 Billion Funding Round from MGX, Coatue, and Thrive Capital

Deep News
·
Mar 25